- Home
- KRMD vs CRNX Comparison
KRMD vs CRNX Comparison
Compare KRMD & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- CRNX
- Stock Information
- Founded
- KRMD 1980
- CRNX 2008
- Country
- KRMD United States
- CRNX United States
- Employees
- KRMD N/A
- CRNX N/A
- Industry
- KRMD Medical/Dental Instruments
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- CRNX Health Care
- Exchange
- KRMD Nasdaq
- CRNX Nasdaq
- Market Cap
- KRMD 134.3M
- CRNX 2.8B
- IPO Year
- KRMD N/A
- CRNX 2018
- Fundamental
- Price
- KRMD $3.63
- CRNX $31.75
- Analyst Decision
- KRMD Strong Buy
- CRNX Strong Buy
- Analyst Count
- KRMD 4
- CRNX 8
- Target Price
- KRMD $4.63
- CRNX $74.86
- AVG Volume (30 Days)
- KRMD 450.7K
- CRNX 725.8K
- Earning Date
- KRMD 08-06-2025
- CRNX 08-07-2025
- Dividend Yield
- KRMD N/A
- CRNX N/A
- EPS Growth
- KRMD N/A
- CRNX N/A
- EPS
- KRMD N/A
- CRNX N/A
- Revenue
- KRMD $35,083,740.00
- CRNX $760,000.00
- Revenue This Year
- KRMD $18.16
- CRNX $402.02
- Revenue Next Year
- KRMD $14.60
- CRNX $771.03
- P/E Ratio
- KRMD N/A
- CRNX N/A
- Revenue Growth
- KRMD 19.65
- CRNX N/A
- 52 Week Low
- KRMD $1.86
- CRNX $24.10
- 52 Week High
- KRMD $5.05
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- KRMD 66.92
- CRNX 57.94
- Support Level
- KRMD $3.54
- CRNX $28.98
- Resistance Level
- KRMD $3.83
- CRNX $32.49
- Average True Range (ATR)
- KRMD 0.20
- CRNX 1.24
- MACD
- KRMD 0.01
- CRNX 0.30
- Stochastic Oscillator
- KRMD 84.80
- CRNX 90.54
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.